1.Clinical Observation of Sulfobenzylpenicillin(Sulbencillin) in Urinary Tract Infection.
Kun Weon CHOO ; Duc Ki YOON ; Min Sung LEE
Korean Journal of Urology 1973;14(4):323-329
The effectiveness of Sulfobenzylpenicillin in the treatment of urinary tract infection was evaluated in the Department of Urology, Seoul National University Hospital during the period from May to November, 1973. Our clinical study was performed on the 28 patients who visited the outpatients clinic and admitted to the ward. These patients were studied by bacterioscopy with Gram's method of staining. and culture in blood agar plate and chocolate agar plate In this studies. the causative organisms were divided into 8 groups; E. coli (5), coagulase positive staphylococcus (5), pseudomonas (2), Corynebacterium spp. (1), a-hemolytic etreptococcus (2), N. Gonorrheae (10), Proteus (2) and KIebsiella (1). The dosage schedule was 1 gm. of Sulfobenzylpenicillin at intervals of 12 hours for consecutive 5 days in gonococcal urethritis and nongonococcal urethritis. But in upper urinary tract infections and post-operative infections, it lasted for 7 to 10 days or more. And following results were obtained. Effectiveness on Urological diseases 1) Gonococcal urethritis; Satisfactory clinical results were obtained with Sulfobenzylpenicillin for five days. Results were excellent in 5 cases, good in 4 cases and negative effect in 1 case. 2) Non-gonococcal urethritis; In this group, the therapeutic results were favorable in 90% of all cases. (excellent-4, good-5, fail-l) 3) Urethral stricture and fistula (2 cases); AII cases were responded to the Sulbenicillin. 4) Cystitis including Prostatism; Two of three cases were caused by E. coli and they had a good response to sulbenicillin. 5) Two cases of pyelonephritis and two cases of postoperative infections were studied with sulbenicillin and more than 60% of cases were effective with sulbenicillin. Side effects were not remarkable but in a few cases who received intramuscular injection, pain on the injection site was noticed.In summary, this new semi-synthetic penicillin is considered to be a useful chemotherapeutic weapon against a variety of infection in the urological field including those due to Gram negative bacilli such as pseudomonas and proteus sp.
Agar
;
Appointments and Schedules
;
Cacao
;
Coagulase
;
Corynebacterium
;
Cystitis
;
Fistula
;
Gonorrhea
;
Humans
;
Injections, Intramuscular
;
Outpatients
;
Penicillins
;
Prostatism
;
Proteus
;
Pseudomonas
;
Pyelonephritis
;
Seoul
;
Staphylococcus
;
Sulbenicillin
;
Urethral Stricture
;
Urethritis
;
Urinary Tract Infections*
;
Urinary Tract*
;
Urologic Diseases
;
Urology
2.Phenolic Constituents and Their Anti-inflammatory Activity from Echinochloa utilis Grains.
Duc Hung NGUYEN ; Bing Tian ZHAO ; Duc Dat LE ; Ki Yun KIM ; Young Ho KIM ; Young Ho YOON ; Jee Youn KO ; Koan Sik WOO ; Mi Hee WOO
Natural Product Sciences 2016;22(2):140-145
Seven phenolic compounds including p-coumaric acid (1), 4-hydroxybenzoic acid (2), 4-hydroxybenzaldehyde (3), vanillic acid (4), luteolin (5), acacetin (6), and tricin (7), were isolated from the methylene chloride and ethyl acetate fractions of Echinochloa utilis grains. Compounds (1 - 4, 6) were isolated for the first time from this plant. These compounds were tested for inhibitory activities against LPS-induced NO production in RAW 264.7 cells. Compounds 5 and 6 displayed significant inhibitory effects, with IC₅₀ values of 27.9 ± 2.6 and 14.0 ± 1.1 µM, respectively. The results suggested that E. utilis ethanolic extract may be used as a potential source of anti-inflammatory agents and functional foods for the treatment of allergic diseases.
Anti-Inflammatory Agents
;
Echinochloa*
;
Ethanol
;
Functional Food
;
Luteolin
;
Methylene Chloride
;
Phenol*
;
Plants
;
RAW 264.7 Cells
;
Vanillic Acid